Weiwei Wu

2.4k citations
31 papers · 1.5k indexed · 1 hit paper · h-index 15

Impact in

  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • interferon and immune responses
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Lymphatic System and Diseases

Papers in

    • Phagocytosis and Immune Regulation 4
    • Immunotherapy and Immune Responses 4
    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
    • CAR-T cell therapy research 7
    • Cancer Immunotherapy and Biomarkers 5

Weiwei Wu

29 papers receiving 1.5k citations

Hit Papers

The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness 2016 · 409 citations
4092016202620192022100200300400

Peers

Weiwei Wu
Comparison fields: 5 of 94
  • Immunology 815
  • Oncology 738
  • Biological Psychiatry 43
  • Behavioral Neuroscience 49
  • Molecular Biology 476
Replace Linda Quatrini with:
Linda Quatrini Italy
Xuejun Zhu China
Bethany L. Mundy-Bosse United States
Aurélie Poli Luxembourg
Wojciech Dawicki Canada
Stephen R. Mattarollo Australia
Kathleen F. Nolan United Kingdom
Wendy K. Nevala United States
Paméla Thébault Canada
Weiwei Wu relative to Linda Quatrini Italy Linda Quatrini's profile →
Citations per field
00.5×
Linda Quatrini · 1×
Citations per year

Countries citing papers authored by Weiwei Wu

Since Specialization
Citations

This map shows the geographic impact of Weiwei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Wu more than expected).

Fields of papers citing papers by Weiwei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Wu. The network helps show where Weiwei Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Weiwei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weiwei Wu Line = papers co-authored together Weiwei Wu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness
Hit paper breakdown →
2016409
2 2017234
3 2005202
4 201997
5 202087
6 201687
7 201382
8 202175
9 201758
10 201142
11 201533
12 201825
13 201622
14 202020
15 202016
16
Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics.
201914
17 20209
18 20158
19 20178
20 20206

About Weiwei Wu

Weiwei Wu is a scholar working on Immunology, Oncology, Biological Psychiatry, Behavioral Neuroscience and Physiology, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Phagocytosis and Immune Regulation (4 papers), Erythrocyte Function and Pathophysiology (4 papers), Immunotherapy and Immune Responses (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Fungal Infections and Studies (3 papers). The work is most often cited by research in Immunology (815 citations), Oncology (738 citations), Biological Psychiatry (43 citations), Behavioral Neuroscience (49 citations) and Molecular Biology (476 citations). Weiwei Wu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Tuoqi Wu, E. Ashley Moseman, Martha Kirby, Luca Gattinoni, Dorian B. McGavern, Pamela L. Schwartzberg, Yun Ji, Robin Handon, Abdel G. Elkahloun and Monica Manglani. Their work appears in journals such as Oncotarget, Molecular Cancer Therapeutics, Cancer Immunology Immunotherapy, Cancer Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026